(Q40629919)

22 September 2017

title

Association of metabolic parameters and rs726344 in FNDC5 with serum irisin concentrations (English)

1 reference

22 September 2017

5

M Stumvoll

1 reference

22 September 2017

7

M Fasshauer

1 reference

22 September 2017

T Ebert

1

1 reference

22 September 2017

S Kralisch

2

1 reference

22 September 2017

U Wurst

3

1 reference

22 September 2017

M Scholz

4

1 reference

22 September 2017

P Kovacs

6

1 reference

22 September 2017

A Tönjes

8

1 reference

22 September 2017

language of work or name

English

0 references

publication date

19 August 2015

1 reference

International Journal of Obesity

22 September 2017

published in

1 reference

22 September 2017

volume

40

1 reference

22 September 2017

issue

2

1 reference

22 September 2017

page(s)

260-265

1 reference

https://scigraph.springernature.com/pub.10.1038/ijo.2015.157

22 September 2017

exact match

0 references

cites work

Regulation of adipocytokines and insulin resistance

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.157

Adipose tissue-derived factors: impact on health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.157

FGF-21 as a novel metabolic regulator

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.157

A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.157

FNDC5/irisin is not only a myokine but also an adipokine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.157

Circulating levels of irisin in patients with anorexia nervosa and different stages of obesity--correlation with body mass index.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.157

Serum levels of irisin in gestational diabetes mellitus during pregnancy and after delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.157

Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.157

Association of serum irisin with metabolic syndrome in obese Chinese adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.157

Common genetic variation in the human FNDC5 locus, encoding the novel muscle-derived 'browning' factor irisin, determines insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.157

Association of FTO variants with BMI and fat mass in the self-contained population of Sorbs in Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.157

Diagnosis and classification of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.157

A new equation to estimate glomerular filtration rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.157

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.157

Circulating irisin in healthy, young individuals: day-night rhythm, effects of food intake and exercise, and associations with gender, physical activity, diet, and body composition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.157

Population-genetic comparison of the Sorbian isolate population in Germany with the German KORA population using genome-wide SNP arrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.157

Genetic variation in the Sorbs of eastern Germany in the context of broader European genetic diversity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.157

Genetics of population isolates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.157

Irisin in patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.157

Effects of lipid-lowering drugs on irisin in human subjects in vivo and in human skeletal muscle cells ex vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.157

Serum levels of the myokine irisin in relation to metabolic and renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.157

Implication of circulating irisin levels with brown adipose tissue and sarcopenia in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.157

Irisin in humans: recent advances and questions for future research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.157

Circulating Adipocyte Fatty Acid-Binding Protein Levels and Cardiovascular Morbidity and Mortality in Patients With Coronary Heart Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.157

Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome: a 5-year prospective study

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26285604

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/IJO.2015.157

1 reference

22 September 2017

1 reference